Shares of DexCom, Inc. (DXCM) rose 0.51% to close at $82.06 on November 18, 2026, as the medical device maker continued a gradual recovery from recent losses. The company's market capitalization stood at $30.44 billion at the close of trading.
Over the past seven days, DXCM has gained 2.66%, reflecting a stabilization in sentiment after a more difficult stretch. The daily uptick contributed to that broader weekly recovery, though the move was measured rather than decisive.
The 30-day picture remains under pressure, with the stock down 4.63% over that period. The gap between the monthly decline and the shorter-term gains suggests the shares have been working to find their footing following a pullback earlier in the month.
DexCom operates in the continuous glucose monitoring segment of the medical device industry. The stock's current price of $82.06 reflects the net result of competing near-term and longer-term price trends visible in the available data.



